LANCET INFECTIOUS DISEASES, cilt.17, sa.7, ss.726-734, 2017 (SCI-Expanded)
Background The best available treatment against carbapenemase-producing Enterobacteriaceae (CPE) is unknown. The objective of this study was to investigate the effect of appropriate therapy and of appropriate combination therapy on mortality of patients with bloodstream infections (BSIs) due to CPE.